Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2002-4-2
pubmed:abstractText
Inhalation of the stable prostacyclin analogue iloprost is being studied for treatment of pulmonary hypertension. The selective phosphodiesterase-5 inhibitor sildenafil has been reported to cause pulmonary vasodilatation.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1539-3704
pubmed:author
pubmed:issnType
Electronic
pubmed:day
2
pubmed:volume
136
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
515-22
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:11926786-3',5'-Cyclic-GMP Phosphodiesterases, pubmed-meshheading:11926786-Administration, Oral, pubmed-meshheading:11926786-Analysis of Variance, pubmed-meshheading:11926786-Area Under Curve, pubmed-meshheading:11926786-Dose-Response Relationship, Drug, pubmed-meshheading:11926786-Drug Synergism, pubmed-meshheading:11926786-Drug Therapy, Combination, pubmed-meshheading:11926786-Female, pubmed-meshheading:11926786-Hemodynamics, pubmed-meshheading:11926786-Humans, pubmed-meshheading:11926786-Hypertension, Pulmonary, pubmed-meshheading:11926786-Iloprost, pubmed-meshheading:11926786-Male, pubmed-meshheading:11926786-Phosphodiesterase Inhibitors, pubmed-meshheading:11926786-Piperazines, pubmed-meshheading:11926786-Purines, pubmed-meshheading:11926786-Sulfones, pubmed-meshheading:11926786-Vasodilator Agents
pubmed:year
2002
pubmed:articleTitle
Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension.
pubmed:affiliation
Department of Internal Medicine, University Hospital, Justus-Liebig-University, Klinikstrasse 36, 35392 Giessen, Germany. ardeschir.ghofrani@innere.med.uni-giessen.de
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't